Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations
Part of paid clinical trials in St Louis, Missouri.
- Sponsor
- Barnes Retina Institute
- Study ID
- NCT00831350
- Phase
- PHASE2
- Status
- Completed
Conditions
- Posterior Vitreous Detachment
- Retinal Vein Occlusion
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Ranibizumab — DRUGSubjects will receive study medication ranibizumab 0.5mg. Re-treatment will occur monthly through 6 injections
Study Details
This is a study of subjects with retinal vein occlusion (RVO) specifically looking at the difference in outcomes between patients with posterior vitreous detachment (PVD) and those without PVD. Posterior vitreous detachment is a condition where the gel-like substance that occupies the space between the retina and the lens of the eye liquefies and separates from the retina. 20 subjects from Barnes Retina Institute will be enrolled in this study. Based on a pre-treatment ultrasound (a test utilizing high-frequency sound waves to look at the inside of the eye), high resolution OCT (a noninvasive procedure called optical coherence tomography to check the thickness of your retina) and clinical exam, subjects will be assigned to one of 2 groups at baseline: Group 1 will be those with PVD and Group 2 will be those without PVD. Then subjects will receive monthly intravitreal (inside the eye) injections of Ranibizumab.
Key Dates
- First listed
- Jan 28, 2009
- Start date
- Apr 30, 2009
- Status verified
- Oct 2017
- Primary completion
- Jul 31, 2011
- Completion
- Dec 31, 2012
Study Design
- Enrollment
- 32 participants (actual)
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ranibizumab
Primary Outcome Measure
Mean change in BCVA at 6 months in the PVD positive and PVD negative ranibizumab-treated groups. [ Time Frame: 6 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Barnes Retina Institute | St Louis | Missouri | 63110 | - |
Find similar trials in St Louis, MO
Related Studies
- National Eye Institute Biorepository for Retinal DiseasesRecruiting · National Eye Institute (NEI) · Bethesda, Maryland
- Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein SodiumEARLY_PHASE1 · Recruiting · MediBeacon · Ann Arbor, Michigan
- Optical Coherence Tomography Angiography in Subjects With Retinal Vascular DiseaseRecruiting · Johns Hopkins University · Baltimore, Maryland
- YAG Laser Vitreolysis for Vitreous FloatersRecruiting · VMR Consulting, Inc. · Huntington Beach, California